Literature DB >> 24750986

Identifying predictors of a difficult thyroidectomy.

Valerie M Mok1, Sarah C Oltmann1, Herbert Chen1, Rebecca S Sippel1, David F Schneider2.   

Abstract

BACKGROUND: A Thyroidectomy Difficulty Scale (TDS) was previously developed that identified more difficult operations, which correlated with longer operative times and higher complication rates. The purpose of this study was to identify preoperative variables predictive of a more difficult thyroidectomy using the TDS.
METHODS: A four item, 20-point TDS, was used to score the difficulty of thyroid operations. Patient and disease factors were recorded for each patient. Difficult thyroidectomy and non-difficult thyroidectomy (NDT) patients were compared. A final multivariate logistic regression model was constructed with significant (P<0.05) variables from a univariate analysis.
RESULTS: A total of 189 patients were scored using TDS. Of them, 69 (36.5%) suffered from hyperthyroidism, 42 (22.2%) from Hashimotos, 34 (18.0%) from thyroid cancer, and 36 (19.0%) from multinodular goiter. Among hyperthyroid patients, the DT group had a greater number preoperatively treated with Lugols potassium iodide (81.6% DT versus 58.1% NDT, P=0.032), presence of ophthalmopathy (31.6% DT versus 9.7% NDT, P=0.028), and presence of (>4 IU/mL) antithyroglobulin antibodies (34.2% DT versus 12.9% NDT, P=0.05). Using multivariate analysis, hyperthyroidism (odds ratio [OR], 4.35, 95% confidence interval [CI], 1.23-15.36, P=0.02), presence of antithyroglobulin antibody (OR, 3.51, 95% CI, 1.28-9.66, P=0.015), and high (>150 ng/mL) thyroglobulin (OR, 2.61, 95% CI, 1.06-6.42, P=0.037) were independently associated with DT.
CONCLUSIONS: Using TDS, we demonstrated that a diagnosis of hyperthyroidism, preoperative elevation of serum thyroglobulin, and antithyroglobulin antibodies are associated with DT. This tool can assist surgeons in counseling patients regarding personalized operative risk and improve OR scheduling.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Difficult thyroidectomy; Difficulty scale; Graves disease; Hashimotos thyroiditis; Risk adjustment; Thyroid

Mesh:

Year:  2014        PMID: 24750986      PMCID: PMC4055556          DOI: 10.1016/j.jss.2014.03.034

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  40 in total

1.  Subjective difficulty of each stage of phacoemulsification cataract surgery performed by basic surgical trainees.

Authors:  Ian J Dooley; Paul D O'Brien
Journal:  J Cataract Refract Surg       Date:  2006-04       Impact factor: 3.351

2.  Evaluating the degree of difficulty of laparoscopic colorectal surgery.

Authors:  Faek R Jamali; Asaad M Soweid; Hani Dimassi; Charles Bailey; Joel Leroy; Jacques Marescaux
Journal:  Arch Surg       Date:  2008-08

3.  Novel thyroidectomy difficulty scale correlates with operative times.

Authors:  David F Schneider; Haggi Mazeh; Sarah C Oltmann; Herbert Chen; Rebecca S Sippel
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

4.  Too frail for surgery? Initial results of a large multidisciplinary prospective study examining preoperative variables predictive of poor surgical outcomes.

Authors:  Louis M Revenig; Daniel J Canter; Maxwell D Taylor; Caroline Tai; John F Sweeney; Juan M Sarmiento; David A Kooby; Shishir K Maithel; Viraj A Master; Kenneth Ogan
Journal:  J Am Coll Surg       Date:  2013-10       Impact factor: 6.113

Review 5.  Comparative effectiveness of therapies for Graves' hyperthyroidism: a systematic review and network meta-analysis.

Authors:  Vishnu Sundaresh; Juan P Brito; Zhen Wang; Larry J Prokop; Marius N Stan; Mohammad H Murad; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2013-07-03       Impact factor: 5.958

6.  Total thyroidectomy: is morbidity higher for Graves' disease than nontoxic goiter?

Authors:  Kellen C Welch; Christopher R McHenry
Journal:  J Surg Res       Date:  2011-04-19       Impact factor: 2.192

7.  American Thyroid Association statement on outpatient thyroidectomy.

Authors:  David J Terris; Samuel Snyder; Denise Carneiro-Pla; William B Inabnet; Emad Kandil; Lisa Orloff; Maisie Shindo; Ralph P Tufano; R Michael Tuttle; Mark Urken; Michael W Yeh
Journal:  Thyroid       Date:  2013-09-14       Impact factor: 6.568

8.  Is thyroidectomy in patients with Hashimoto thyroiditis more risky?

Authors:  Catherine McManus; Jie Luo; Rebecca Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2012-10-01       Impact factor: 2.192

9.  Total thyroidectomy for Graves' disease treatment.

Authors:  A Catania; E Guaitoli; G Carbotta; M Bianchini; F M Di Matteo; S Carbotta; M Nardi; E Fabiani; G Grani; V D'Andrea; A Fumarola
Journal:  Clin Ter       Date:  2013 May-Jun

10.  Is potassium iodide solution necessary before total thyroidectomy for Graves disease?

Authors:  Myrick C Shinall; James T Broome; Arielle Baker; Carmen C Solorzano
Journal:  Ann Surg Oncol       Date:  2013-07-12       Impact factor: 5.344

View more
  10 in total

1.  Assessing American Thyroid Association Guidelines for Total Thyroidectomy in Graves' Disease.

Authors:  Siddique Akram; Dawn M Elfenbein; Herbert Chen; David F Schneider; Rebecca S Sippel
Journal:  J Surg Res       Date:  2019-08-08       Impact factor: 2.192

2.  An evaluation score of the difficulty of thyroidectomy considering operating time and preservation of recurrent laryngeal nerve.

Authors:  Salvatore Vieni; Giuseppa Graceffa; Giacomo E M Rizzo; Federica Latteri; Mario A Latteri; Calogero Cipolla
Journal:  Updates Surg       Date:  2018-11-15

3.  Risk factors for difficult thyroidectomy and postoperative morbidity do not match: retrospective study from an endocrine surgery academic referral centre.

Authors:  F P Prete; P C Panzera; G Di Meo; A Pasculli; L I Sgaramella; G Calculli; R Dimonte; F Ferrarese; M Testini; A Gurrado
Journal:  Updates Surg       Date:  2022-09-05

4.  Impact of potassium iodide on thyroidectomy for Graves' disease: Implications for safety and operative difficulty.

Authors:  Reese W Randle; Maria F Bates; Kristin L Long; Susan C Pitt; David F Schneider; Rebecca S Sippel
Journal:  Surgery       Date:  2017-11-03       Impact factor: 3.982

5.  Energy vessel sealant devices are associated with decreased risk of neck hematoma after thyroid surgery.

Authors:  Katherine Moran; Areg Grigorian; Dawn Elfenbein; Sebastian Schubl; Zeljka Jutric; Michael Lekawa; Jeffry Nahmias
Journal:  Updates Surg       Date:  2020-04-24

6.  The significance of Hashimoto's thyroiditis for postoperative complications of thyroid surgery: a systematic review and meta-analysis.

Authors:  X Gan; J Feng; X Deng; F Shen; J Lu; Q Liu; W Cai; Z Chen; M Guo; B Xu
Journal:  Ann R Coll Surg Engl       Date:  2021-03       Impact factor: 1.951

7.  Determinants of operative time in thyroid surgery: A prospective multicenter study of 3454 thyroidectomies.

Authors:  Arnaud Patoir; Cécile Payet; Jean-Louis Peix; Cyrille Colin; Léa Pascal; Jean-Louis Kraimps; Fabrice Menegaux; François Pattou; Frédéric Sebag; Sandrine Touzet; Stéphanie Bourdy; Jean-Christophe Lifante; Antoine Duclos
Journal:  PLoS One       Date:  2017-07-27       Impact factor: 3.240

8.  Thyroiditis process as a predictive factor of sternotomy in the treatment of cervico-mediastinal goiter.

Authors:  Claudio Casella; Sarah Molfino; Carlo Cappelli; Federica Salvoldi; Mauro Roberto Benvenuti; Nazario Portolani
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

9.  Patient, thyroid, and surgeon related factors that make thyroidectomy difficult-cohort study.

Authors:  Sapana Bothra; Mayilvaganan Sabaretnam; Asish Kannujia; Gyan Chand; Gaurav Agarwal; S K Mishra; Amit Agarwal
Journal:  Ann Med Surg (Lond)       Date:  2019-11-23

10.  May predictors of difficulty in thyroid surgery increase the incidence of complications? Prospective study with the proposal of a preoperative score.

Authors:  Valerio D'Orazi; Andrea Sacconi; Silvia Trombetta; Menelaos Karpathiotakis; Daniele Pichelli; Enrico Di Lorenzo; Alice Ortensi; Paolo Urciuoli; Marco Biffoni; Andrea Ortensi
Journal:  BMC Surg       Date:  2019-04-24       Impact factor: 2.102

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.